Consequences of different definitions of confirmed disability progression across randomized trials of multiple sclerosis therapies

N Bergvall, N Sfikas, J Alsop, P Chin, P von Rosenstiel, L Kappos

European Committee for Treatment & Research in Multiple Sclerosis 2012

The presentation that you are looking for is no longer available on this site. Please contact Novartis Oncology Medical Information at 1-844-ONC-INFO (1-844-662-4636).